Cargando…

Use of Intravesical Chemotherapy in the US Following Publication of a Randomized Clinical Trial

This cross-sectional study examines the use of intravesical chemotherapy after transurethral resection of bladder tumor before and after publication of a randomized clinical trial showing the benefits of intravesical chemotherapy.

Detalles Bibliográficos
Autores principales:	Lewicki, Patrick, Basourakos, Spyridon P., Arenas-Gallo, Camilo, Qiu, Yuqing, Prunty, Megan, Scherr, Douglas S., Shoag, Jonathan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889460/ https://www.ncbi.nlm.nih.gov/pubmed/35230440 http://dx.doi.org/10.1001/jamanetworkopen.2022.0602

Ejemplares similares

Changes in Urologic Operative Practice at the Beginning of the COVID-19 Pandemic in a Large, National Cohort
por: Lewicki, Patrick, et al.
Publicado: (2021)

Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide Cohort
por: Lewicki, Patrick, et al.
Publicado: (2021)

Reply to Tommy Jiang, Sriram V. Eleswarapu, and Vadim Osadchiy’s Letter to the Editor re: Patrick Lewicki, Spyridon P. Basourakos, Bashir Al Hussein Al Awamlh, et al. Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide Cohort. Eur Urol Open Sci 2021;25:52–6. Impact of the COVID-19 Pandemic on Kidney Stones: Matching Online Discussions to Real World Data
por: Lewicki, Patrick, et al.
Publicado: (2021)

The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers
por: O’Brian, Daniel, et al.
Publicado: (2021)

Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer
por: Basourakos, Spyridon P., et al.
Publicado: (2021)

Outpatient robotic assisted retroperitoneal lymph node dissection
por: Basourakos, Spyridon P., et al.
Publicado: (2022)

Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy
por: Moriarty, Michael A., et al.
Publicado: (2015)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression
por: Delto, Joan C., et al.
Publicado: (2013)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
por: Liu, Ching-Wen, et al.
Publicado: (2016)

Intravesical migration of an intrauterine device
por: Gyasi-Sarpong, Christian Kofi, et al.
Publicado: (2016)

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
por: Ruan, Qiang, et al.
Publicado: (2021)

Treatment patterns and survival of low and intermediate‐risk prostate cancer in end‐stage kidney disease: A retrospective population cohort study
por: Sarabu, Nagaraju, et al.
Publicado: (2023)

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
por: Serretta, Vincenzo, et al.
Publicado: (2015)

Gel-Based Nanocarrier for Intravesical Chemotherapy Delivery: In Vitro and In Vivo Study
por: Chen, Ting-Yu, et al.
Publicado: (2020)

Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
por: Lu, Yilei, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on semen parameters
por: Basourakos, Spyridon P., et al.
Publicado: (2022)

Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
por: Brant, Aaron, et al.
Publicado: (2022)

Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?
por: Anastay, Vassili, et al.
Publicado: (2023)

Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: Comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection
por: Naya, Yoshio, et al.
Publicado: (2018)

The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study
por: Zhou, Zhongbao, et al.
Publicado: (2021)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
por: Chowdhury, Anadi Roy, et al.
Publicado: (2013)

Unusual Intravesical Foreign Body Following Perineo-vesical Injury
por: Ezenwa, Ekene Victor, et al.
Publicado: (2018)

Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer
por: Seegobin, Karan, et al.
Publicado: (2017)

Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips
por: Zhu, Alec, et al.
Publicado: (2022)

Intravesical Separation of the Urines
Publicado: (1905)

Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer
por: Guo, Hui, et al.
Publicado: (2018)

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018)

Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy
por: Chen, Ting-Yu, et al.
Publicado: (2020)

Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study
por: Sasaki, Noboru, et al.
Publicado: (2022)

A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
por: Van Hattum, J. W., et al.
Publicado: (2022)

Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer
por: Chen, Cheng‐Che, et al.
Publicado: (2023)

1362. A Novel Intravesical Antimicrobial for CAUTIs
por: Peterson, Marnie, et al.
Publicado: (2018)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
por: Liu, Yuqing, et al.
Publicado: (2019)

The different predictive value of mean platelet volume-to-lymphocyte ratio for postoperative recurrence between non-muscular invasive bladder cancer patients treated with intravesical chemotherapy and intravesical chemohyperthermia
por: Wang, Chengbo, et al.
Publicado: (2023)

Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer
por: Mackel, Charles E, et al.
Publicado: (2016)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018)

Tuberculosis epididymo-orchitis following intravesical bacillus Calmette-Guérin immunotherapy
por: Rezvani, Sean, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mkttckrpbrrhn0v45aoq02c2gr